KALRN Human Pre-designed siRNA Set A contains three designed siRNAs for KALRN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KANK1 Human Pre-designed siRNA Set A contains three designed siRNAs for KANK1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KANK2 Human Pre-designed siRNA Set A contains three designed siRNAs for KANK2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KANK3 Human Pre-designed siRNA Set A contains three designed siRNAs for KANK3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KANK4 Human Pre-designed siRNA Set A contains three designed siRNAs for KANK4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Kanosamine (3-Amino-3-deoxyglucose) is an antibiotic against Saccharomyces cerevisiae and human pathogenic fungi Candida albicans. Kanosamine exhibits antifungal activity through inhibition of cell wall synthesis and inhibition of GlcN-6-P synthase with phosphorylated kanosamine-6-phosphate in cytoplasma[1][2].

KANSL1 Human Pre-designed siRNA Set A contains three designed siRNAs for KANSL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KANSL2 Human Pre-designed siRNA Set A contains three designed siRNAs for KANSL2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KANSL3 Human Pre-designed siRNA Set A contains three designed siRNAs for KANSL3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KANTR Human Pre-designed siRNA Set A contains three designed siRNAs for KANTR gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KARS1 Human Pre-designed siRNA Set A contains three designed siRNAs for KARS1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Kartogenin (KGN) sodium is an inducer of chondrogenic tissue formation (EC50: 100 nM). Kartogenin sodium induces chondrogenesis by binding to fibrin A, disrupting its interaction with the transcription factor core binding factor beta subunit (CBFβ), and by modulating the CBFβ-RUNX1 transcriptional program. Kartogenin sodium also promotes tendon-bone junction (TBJ) wound healing by stimulating collagen synthesis. […]

Kartogenin (KGN) sodium is an inducer of chondrogenic tissue formation (EC50: 100 nM). Kartogenin sodium induces chondrogenesis by binding to fibrin A, disrupting its interaction with the transcription factor core binding factor beta subunit (CBFβ), and by modulating the CBFβ-RUNX1 transcriptional program. Kartogenin sodium also promotes tendon-bone junction (TBJ) wound healing by stimulating collagen synthesis. […]

Kartogenin (KGN) sodium is an inducer of chondrogenic tissue formation (EC50: 100 nM). Kartogenin sodium induces chondrogenesis by binding to fibrin A, disrupting its interaction with the transcription factor core binding factor beta subunit (CBFβ), and by modulating the CBFβ-RUNX1 transcriptional program. Kartogenin sodium also promotes tendon-bone junction (TBJ) wound healing by stimulating collagen synthesis. […]

KASH5 Human Pre-designed siRNA Set A contains three designed siRNAs for KASH5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KAT14 Human Pre-designed siRNA Set A contains three designed siRNAs for KAT14 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KAT2A Human Pre-designed siRNA Set A contains three designed siRNAs for KAT2A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Kat2a Mouse Pre-designed siRNA Set A contains three designed siRNAs for Kat2a gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Kat2a Rat Pre-designed siRNA Set A contains three designed siRNAs for Kat2a gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

KAT2B Human Pre-designed siRNA Set A contains three designed siRNAs for KAT2B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Kat2b Mouse Pre-designed siRNA Set A contains three designed siRNAs for Kat2b gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

KAT2B Rat Pre-designed siRNA Set A contains three designed siRNAs for KAT2B gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

KAT5 Human Pre-designed siRNA Set A contains three designed siRNAs for KAT5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KAT6A Human Pre-designed siRNA Set A contains three designed siRNAs for KAT6A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KAT6B Human Pre-designed siRNA Set A contains three designed siRNAs for KAT6B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KAT7 Human Pre-designed siRNA Set A contains three designed siRNAs for KAT7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KAT8 Human Pre-designed siRNA Set A contains three designed siRNAs for KAT8 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KATNAL1 Human Pre-designed siRNA Set A contains three designed siRNAs for KATNAL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KATNAL2 Human Pre-designed siRNA Set A contains three designed siRNAs for KATNAL2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KATNB1 Human Pre-designed siRNA Set A contains three designed siRNAs for KATNB1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KATNIP Human Pre-designed siRNA Set A contains three designed siRNAs for KATNIP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KAZALD1 Human Pre-designed siRNA Set A contains three designed siRNAs for KAZALD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KAZN Human Pre-designed siRNA Set A contains three designed siRNAs for KAZN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KB-0742 is a potent, selective and orally active CDK9 inhibitor with an IC50 of 6 nM for CDK9/cyclin T1. KB-0742 is selective for CDK9/cyclin T1 with >50-fold selectivity over other CDK kinases. KB-0742 has potent anti-tumor activity[1].

KBTBD11 Human Pre-designed siRNA Set A contains three designed siRNAs for KBTBD11 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KBTBD13 Human Pre-designed siRNA Set A contains three designed siRNAs for KBTBD13 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.